Bucheon, South Korea

Tae-hoon Kim

This inventor holds 1 USPTO granted patent. Top assignee: Yuhan Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tae-hoon Kim. Retrieved from https://idiyas.com/inventor/tae-hoon-kim-3w7d34im

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tae-hoon Kim: Innovator in Pharmaceutical Compounds

Introduction

Tae-hoon Kim is a notable inventor based in Bucheon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on fused ring compounds.

Latest Patents

Tae-hoon Kim holds 1 patent for a fused ring compound containing furan or a pharmaceutically acceptable salt thereof. This invention provides a method for preparing the compound, a pharmaceutical composition comprising it, and its various uses. The compound is designed to inhibit the activity of phosphatidylinositol 3-kinase (PI3K), making it valuable for treating and preventing respiratory diseases, inflammatory diseases, proliferative diseases, cardiovascular diseases, and central nervous system diseases that arise from the over-activation of PI3K.

Career Highlights

Tae-hoon Kim is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to focus on developing innovative solutions to complex health issues.

Collaborations

Some of his notable coworkers include Hyoung Sig Seo and Tae Kyun Kim, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Tae-hoon Kim's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…